Cambridge, MA, United States of America

Guochuan Tsai

This inventor holds 6 USPTO granted patents. Top assignees: The General Hospital Corporation, The General Hosptial Corporation. Active years: 2001-2010.


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 2001-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Guochuan Tsai: Innovator in Neuropsychiatric Treatments

Introduction

Guochuan Tsai is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of neuropsychiatric disorders through his innovative research and patented methods. With a total of 6 patents, Tsai's work focuses on developing effective treatments for various mental health conditions.

Latest Patents

Tsai's latest patents include groundbreaking methods for treating neuropsychiatric disorders such as schizophrenia, Alzheimer's Disease, autism, depression, benign forgetfulness, childhood learning disorders, closed head injury, and attention deficit disorder. The methods involve administering a pharmaceutical composition that contains a therapeutically effective amount of D-alanine or its modified forms, D-serine, D-cycloserine, and N-methylglycine, ensuring that the composition is substantially free of D-cycloserine in certain formulations.

Career Highlights

Throughout his career, Guochuan Tsai has worked with notable institutions, including The General Hospital Corporation. His research has been pivotal in advancing the understanding and treatment of neuropsychiatric disorders, making him a key figure in this field.

Collaborations

Some of Tsai's notable coworkers include Joseph Coyle and Xudong Huang, who have collaborated with him on various research projects aimed at improving mental health treatments.

Conclusion

Guochuan Tsai's innovative work in neuropsychiatric treatments has the potential to significantly impact the lives of individuals suffering from mental health disorders. His contributions to the field are invaluable and continue to inspire further research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…